392721-37-8CC(=O)CC(=O)Nc1ccc(Cl)c(C(F)(F)F)c1GNYIJZMBLZXJEJ-UHFFFAOYSA-Nchemical sensitizer to death receptor stimuli FAS; structure in first source
392721-37-8DTXSID60358175CHEMBL6134474Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.
DescriptionFasentin (392721-37-8) is a novel inhibitor of glucose uptake which acts via inhibition of the glucose transporter GluT1 and GluT4 (IC50=68 μM).1Inhibition of glucose uptake is cell type specific2and is a promising approach to new cancer therapeutics3. Rescues cardiac progenitor cell dysfunction and mitochondrial fission induced by high glucose.4Sensitizes cells to FAS-induced cell death.5,6
UsesFasentin is a novel glucose transport inhibitor that blocks glucose uptake and is also a chemical sensitizer to the death receptor stimuli FAS and tumor necrosis factor apoptosis-inducing ligand.
UsesFasentin has been used as a glucose transporter (GLUT1) inhibitor to assess its effects on the vulnerability of a wide range of triple-negative breast cancer (TNBC) cell lines and to study its effects on cytotoxic drugs induced by hydrocortisone (HC).
Loading…
Loading…
No reaction records under the current filter.
Loading…